EGFR essential for the development of pancreatic cancer
2011-09-16
(Press-News.org) SAN FRANCISCO — The epidermal growth factor receptor (EGFR) gene is essential for KRAS-driven pancreatic cancer development, according to study results presented at the Second AACR International Conference on Frontiers in Basic Cancer Research, held here Sept. 14-18, 2011.
The mutation of the KRAS gene has been found to be an important component in the development of many cancers, including pancreatic cancer. However, Barbara M. Gruener, researcher at the Technical University in Munich, Germany, said that despite the presence of KRAS, the development of preneoplastic precursor lesions and pancreatic ductal adenocarcinoma is blocked without the EGF receptor.
"These results revealed an unappreciated central role of EGFR very early in the carcinogenic process," said Gruener, who is a doctoral student at the university.
Gruener and colleagues compared more than 40 mice with the pancreas-specific deletion of EGFR with the KRAS mouse model for pancreatic cancer.
"Contrary to current opinion, we showed that lack of EGFR blocks the development of pancreatic cancer," she said. "Originally, we wanted to characterize the known role of EGFR in pancreatic cancer to a higher extent so that EGFR targeted therapy could be more individualized."
Gruener said the results were not what researchers had expected and were surprising.
"With oncogenic active KRAS, you would expect that the lack of a receptor that is upstream of the KRAS signaling pathway does not impair the carcinogenic effects of KRAS almost completely," she said.
###
Follow the AACR on Twitter: @aacr #aacr
Follow the AACR on Facebook: http://www.facebook.com/aacr.org
The mission of the American Association for Cancer Research is to prevent and cure cancer. Founded in 1907, the AACR is the world's oldest and largest professional organization dedicated to advancing cancer research. The membership includes 33,000 basic, translational and clinical researchers; health care professionals; and cancer survivors and advocates in the United States and more than 90 other countries. The AACR marshals the full spectrum of expertise from the cancer community to accelerate progress in the prevention, diagnosis and treatment of cancer through high-quality scientific and educational programs. It funds innovative, meritorious research grants, research fellowships and career development awards. The AACR Annual Meeting attracts more than 18,000 participants who share the latest discoveries and developments in the field. Special conferences throughout the year present novel data across a wide variety of topics in cancer research, treatment and patient care. The AACR publishes seven major peer-reviewed journals: Cancer Discovery; Cancer Research; Clinical Cancer Research; Cancer Epidemiology, Biomarkers & Prevention; Molecular Cancer Therapeutics; Molecular Cancer Research; and Cancer Prevention Research. AACR journals received 20 percent of the total number of citations given to oncology journals in 2010.
END
ELSE PRESS RELEASES FROM THIS DATE:
2011-09-16
SAN FRANCISCO — Researchers are investigating a potential treatment and noninvasive imaging modality for pancreatic cancer that shows promise, according to researchers at Memorial Sloan-Kettering Cancer Center in New York, N.Y., and Genelux Corporation in San Diego, Calif.
The vaccinia virus construct GLV-1h153, engineered to encode for the human sodium iodide symporter gene (hNIS), is a promising candidate for viro-therapy of cancer and for long-term noninvasive monitoring of therapeutic response via deep tissue imaging modalities such as positron emission tomography ...
2011-09-16
SAN FRANCISCO — Researchers are working to discover how genes interact with each other to lead to cancer progression. This research is expected to lead the way toward the discovery of new targeted therapies against breast cancer, according to a study presented at the Second AACR International Conference on Frontiers in Basic Cancer Research, held here Sept. 14-18, 2011.
For example, the researchers found that a diuretic used to treat hypertension and edema also stops breast cancer cells from progressing, although this potential treatment is a long way from human trials, ...
2011-09-16
The escalating cost of homeowners insurance ought not to deter homeowners from getting the best rates. Insure4USA.com, a leading online insurance service recently released a new comparison tool where homeowners can compare quotes amongst the leading insurance providers in the country. According to David, manager of Insure4USA.com, there has been a significant increase in the number of homeowners who now choose to purchase a policy online rather than merely research. David says, "Our new comparison tool is the first step in finding the best homeowners insurance policy ...
2011-09-16
Washington, D.C. — A planet with two suns may be a familiar sight to fans of the "Star Wars" film series, but not, until now, to scientists. A team of researchers, including Carnegie's Alan Boss, has discovered a planet that orbits around a pair of stars. Their remarkable findings will be published Sept. 16 in Science.
This is the first instance of astronomers finding direct evidence of a so-called circumbinary planet. A few other planets have been suspected of orbiting around both members of a dual-star system, but the transits of the circumbinary planet have never been ...
2011-09-16
Apples and pears may keep strokes away.
That's the conclusion of a Dutch study published in Stroke: Journal of the American Heart Association in which researchers found that eating a lot of fruits and vegetables with white flesh may protect against stroke.
While previous studies have linked high consumption of fruits and vegetables with lower stroke risk, the researchers' prospective work is the first to examine associations of fruits and vegetable color groups with stroke.
The color of the edible portion of fruits and vegetables reflects the presence of beneficial ...
2011-09-16
Shutterfly, Inc. (NASDAQ:SFLY), a leading Internet-based social expression and personal publishing service, today releases an expanded lineup of baby stationery. From modern and traditional to bright and brilliant design styles, Shutterfly's baby collection features more than 170 new birth announcements, a fresh bundle of baby shower invitations and corresponding thank you cards, perfect for new parents and expanding families.
"Shower invitations and birth announcements are a wonderful way to celebrate the birth of your baby and share the news with family and friends," ...
2011-09-16
If solar cells could generate higher voltages when sunlight falls on them, they'd produce more electrical power more efficiently. For over half a century scientists have known that ferroelectrics, materials whose atomic structure allows them to have an overall electrical polarization, can develop very high photovoltages under illumination. Until now, no one has figured out exactly how this photovoltaic process occurs.
Now a team of researchers at the U.S. Department of Energy's Lawrence Berkeley National Laboratory (Berkeley Lab) and the University of California at Berkeley ...
2011-09-16
Jagged Peak, Inc. (OTC BB: JGPK), a leading provider of enterprise-class eCommerce solutions and supply chain services announced today the successful launch of www.footpetals.com using the EDGE eCommerce platform to power the front-end website and order management. This is the second such site for the accessories company since January.
The EDGE platform is recognized as a best-of-breed eCommerce solution, and is used by many of the world's leading consumer products companies to deploy their web stores and optimize their supply chain operations. The EDGE platform contains ...
2011-09-16
PHILADELPHIA — Glioblastoma is among the most lethal cancers, but scientists have uncovered a novel growth mechanism that suggests patients with glioblastoma could be treated with cholesterol-lowering agents, according to a study published in Cancer Discovery, the newest journal of the American Association for Cancer Research.
Lead researcher Paul Mischel, M.D., Lya and Harrison Latta professor of pathology and laboratory medicine, and professor of molecular and medical pharmacology at the David Geffen School of Medicine at the University of California, Los Angeles, ...
2011-09-16
Lumeneering Inc. (Mountainview CA) has entered into a partnership with the McMaster Manufacturing Research Institute at McMaster University in Hamilton, Ontario to research and develop the recycling and manufacture of the Luma One light-emitting diode panel. The partnership is funded under the Engage program of the Natural Sciences and Engineering Research Council of Canada (NSERC).
"We are confident that the University will deliver the most innovative product design and manufacturing process for our Luma One panels," said Michael R. Freeman, Lumeneering's ...
LAST 30 PRESS RELEASES:
[Press-News.org] EGFR essential for the development of pancreatic cancer
